Stay updated on Targeted Therapy for Incurable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Targeted Therapy for Incurable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Targeted Therapy for Incurable Lung Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-13T22:49:15.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the objective response rate among patients with high PD-L1 expressing cancers after failure of targeted therapy in a phase II trial focusing on treating patients with incurable non-small cell lung cancer with a genetic mutation.
    Difference
    0.1%
    Check dated 2024-06-06T14:45:21.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' The new description provides examples of eligibility criteria, such as a person's general health condition or prior treatments.
    Difference
    20%
    Check dated 2024-05-22T21:37:58.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:26:27.000Z thumbnail image

Stay in the know with updates to Targeted Therapy for Incurable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Targeted Therapy for Incurable Lung Cancer Clinical Trial page.